Cargando…

653. Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose

BACKGROUND: At the University of Kentucky Medical center (UKMC), positive fungal blood cultures are concurrently run through the Biofire Blood Culture Identification (BCID) panel which detects 5 Candida species. The newer platform, the GenMarkDx ePlex BCID-FP (fungal panel) is designed to detect 16...

Descripción completa

Detalles Bibliográficos
Autores principales:	lin, jeffrey, Myint, Thein, Arora, Vaneet, Ribes, Julie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776130/ http://dx.doi.org/10.1093/ofid/ofaa439.847

Ejemplares similares

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

164. Performance of ePlex® Blood Culture Identification Panels in Clinical Isolates and Characterization of Antimicrobial Stewardship Opportunities
por: Thomas, Jenni, et al.
Publicado: (2023)

1326. Comparison of Positive BioFire® FilmArray® Meningitis Encephalitis (ME) Panels, CSF cultures, CSF Parameters and Inpatient Mortality Among Patients with Bacterial and Fungal Meningitis
por: Myint, Thein, et al.
Publicado: (2023)

214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections
por: Huang, Te-Din, et al.
Publicado: (2019)

1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021)

Evaluation of point of care testing platform (ePLEX) for respiratory viral diagnosis
por: Guerendiain, Daniel, et al.
Publicado: (2016)

359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022)

Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel
por: Carroll, Karen C., et al.
Publicado: (2020)

The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022)

Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex(®) Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia
por: Bryant, Sabrina, et al.
Publicado: (2020)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: McCarty, T. P., et al.
Publicado: (2023)

1705. Clinical Characteristics and Outcomes of Cryptococcosis in a Tertiary Care Center in Kentucky, 2005 to 2017
por: Bhatt, Mahesh, et al.
Publicado: (2019)

1713. Impact of False-Positive Low-Titer Cryptococcal Antigen Testing
por: Bhatt, Mahesh, et al.
Publicado: (2019)

A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: Wolk, Donna M., et al.
Publicado: (2021)

Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs
por: Babady, N. Esther, et al.
Publicado: (2018)

Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR
por: van Rijn, Anneloes L., et al.
Publicado: (2017)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

653. Direct Identification of Microorganisms in Positive Blood Cultures by the BioFire® FilmArray® Blood Culture Identification Panel Leads to Faster Optimal Antibiotic Therapy: A Before–After Study
por: Agnetti, Jessica, et al.
Publicado: (2021)

Evaluation of the Genmark ePlex® and QIAstat-Dx® respiratory pathogen panels in detecting bacterial targets in lower respiratory tract specimens
por: van Asten, Suzanne A. V., et al.
Publicado: (2021)

1027. Earlier Is Better: Progress Toward Decreased Time to Optimal Therapy and Improved Antibiotic Stewardship for Gram-positive Bloodstream Infections Through Use of GenMark Dx ePlex system
por: White, Cameron, et al.
Publicado: (2021)

A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures
por: Tansarli, Giannoula S., et al.
Publicado: (2022)

300. Pediatric Center Evaluation of the BioFire(®) Blood Culture Identification 2 Panel Versus the Original BioFire(®)FilmArray(®) Blood Culture Identification Panel for the Detection of Microorganisms and Resistance Markers in Positive Blood Cultures
por: Pierce, Kristina B, et al.
Publicado: (2020)

1156. Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
por: Cari, Evelyn Villacorta, et al.
Publicado: (2020)

1020. BioFiring on all Cylinders: Validation of BioFire FilmArray Pneumonia Panel and Determination of Optimal Utility
por: Strength, Rachel, et al.
Publicado: (2021)

P653: CML LONG-TERM LEUKEMIC STEM CELL PERSISTENCE IS INFLUENCED BY MYELOFIBROSIS AT DIAGNOSIS
por: Jacobi, Henrike, et al.
Publicado: (2023)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

To PLEX or Not to PLEX for Amiodarone-Induced Thyrotoxicosis
por: Ahuja, Tania, et al.
Publicado: (2023)

Multiplex size marker (YEAST PLEX) for rapid and accurate identification of pathogenic yeasts
por: Aboutalebian, Shima, et al.
Publicado: (2022)

640. Analytical Validation of the BioFire(®) Bone and Joint Infection (BJI) Panel for the Identification of Bacteria, Yeast, and Antimicrobial Resistance Genes from Synovial Fluid
por: Francis, Nicholas, et al.
Publicado: (2020)

Multicenter Evaluation of the BIOFIRE Blood Culture Identification 2 Panel for Detection of Bacteria, Yeasts, and Antimicrobial Resistance Genes in Positive Blood Culture Samples
por: Rhoads, Daniel D., et al.
Publicado: (2023)

653 Perceived stress among low income pregnant women in during the COVID-19 pandemic
por: Kuppermann, Miriam, et al.
Publicado: (2021)

1982. A Diagnostic Stewardship Intervention for Clostridioides difficile: Impact of Stool Toxin Testing on Treatment of Adult Inpatients
por: Moss, Jason, et al.
Publicado: (2019)

653. To Treat or Not to Treat Corynebacterium striatum? That is the Question
por: Soriano, Katrina, et al.
Publicado: (2018)

123. Utilization of the BioFire® FilmArray® Pneumonia Panel in Critically Ill Patients with Influenza Pneumonia
por: Ereshefsky, Benjamin, et al.
Publicado: (2020)

1368. The Clinical Impact of BioFire BCID2 Compared to BCID in a U.S. Pediatric Hospital
por: Graff, Kelly E, et al.
Publicado: (2020)

Long-term survival in lung transplant recipients depending on icu length of stay: outcome in a series of 653 consecutive patients
por: Zemtsovski, M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t7n1e3nvi89le2hnjfm105hcpq